Your session is about to expire
← Back to Search
Pyridostigmine for Postural Tachycardia Syndrome
Study Summary
This trial will compare the effects of pyridostigmine to placebo in treating postural tachycardia syndrome. The researchers expect that pyridostigmine will improve tachycardia and stabilize blood pressure.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a condition called postural tachycardia syndrome, which is diagnosed when your heart rate goes up by 30 or more beats per minute within 5 minutes of standing up.You have a thyroid condition that is not under control.You have been diagnosed with postural tachycardia syndrome.Your heart rate increases by 30 or more beats per minute within 5 minutes of standing up.You experience symptoms like feeling weak, dizzy, having blurry vision, feeling sick to your stomach, and having trouble focusing when you stand up.You have a serious illness or organ problems that could affect how your body functions, or you may have trouble following study instructions.You have a serious heart condition related to your arteries.You are taking medications that could affect the results of the autonomic testing.You have not taken pyridostigmine for POTS in the last month.You have been diagnosed with postural tachycardia syndrome, which causes symptoms like feeling dizzy and having trouble concentrating when standing up.
- Group 1: Placebo
- Group 2: pyridostigmine
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the aggregate count of participants involved in this research?
"Affirmative. Clinicaltrials.gov has evidence of this clinical trial's current recruitment status, which began on October 1st 2006 and was refreshed on March 4th 2022. The study will be enrolling 50 participants from one specific medical centre."
What are the eligibility requirements to join this research project?
"This scientific investigation is searching for 50 participants with the illness, aged between 15 and 55. If they meet these criteria, they will be eligible to join the trial."
What medical purposes does pyridostigmine typically serve?
"Pyridostigmine has been seen to ameliorate myasthenia gravis, dyschezia, and orthostatic syncope."
Might participants older than fifty-five years be qualified to join this research?
"The requirements for enrollment in this trial is that patients must be between the ages of 15 and 55. Separately, there are 388 studies targeting individuals below 18 years old and 1,075 experiments focused on those 65 or older."
Is enrollment in this scientific experiment still an option for participants?
"This clinical trial, which was initially posted on October 1st 2006 and most recently edited March 4th 2022 is still recruiting participants."
Have there been other experiments performed with pyridostigmine?
"Currently, 4 clinical trials that focus on pyridostigmine are actively enrolling participants with none of them in Phase 3. Of these locations, there is one based in Nashville, Tennessee and three other study centres scattered across the country."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger